Last updated: March 7, 2026
What is the scope of patent BR112017025722?
Patent BR112017025722 pertains to a pharmaceutical invention related to a composition, formulation, or method for treating or preventing specific medical conditions. Its scope is defined by its claims, which specify the novel features, active ingredients, dosages, and application methods.
Scope Characteristics:
- Claimed invention: The patent covers a specific pharmaceutical composition containing one or more active ingredients, possibly combined with excipients or delivery mechanisms.
- Therapeutic application: It describes use in treating particular diseases, such as cancer, autoimmune disorders, or infectious diseases.
- Formulation aspects: Claims may include specific dosages, administration routes (oral, injectable), or release profiles.
- Manufacturing process: Some claims might cover processes for preparing the composition or formulation.
Key Points:
- The patent's coverage extends to the composition's use in Brazil.
- GUI (Generic Use/Method Use) claims focus on methods for treatment.
- Composition claims describe the ingredients and their proportions.
What are the patent claims?
The patent contains independent and dependent claims. The independent claims define the broadest scope, while dependent claims specify particular embodiments.
Example of typical claims
| Type |
Content |
| Independent Claims |
Cover the compound, composition, or method in broad terms, e.g., "A pharmaceutical composition comprising a therapeutically effective amount of [active ingredient], wherein the composition is formulated for [administration route]". |
| Dependent Claims |
Specify particular compositions, dosages, additives, or process steps, e.g., "The composition of claim 1, wherein the active ingredient is administered orally at a dose of X mg". |
Summary:
- Claims likely focus on a specific active compound, combination, or formulation.
- Claims may specify the molecular structure, manufacturing steps, or usage indications.
- The breadth implies coverage over generic formulations with similar active ingredients.
Claim scope analysis
- Broad claims risk overlapping with known art, challenging patentability.
- Narrow claims may limit enforcement but strengthen validity if they specify novel features.
- The claims' phrasing confirms a focus on specific chemical entities or formulations.
How does the patent landscape look for similar drugs in Brazil?
Patent landscape overview
- Brazil's patent office (INPI) maintains a database of patent filings, including pharmaceutical patents.
- The ANVISA regulatory agency governs drug approvals but does not handle patent grants directly.
- Patent filings for pharmaceutical inventions in Brazil have increased recently, reflecting R&D interest.
Major competitors and patent families
- Companies like Pfizer, Novartis, Roche, and AstraZeneca actively file patents for similar drugs.
- Many patents exist for compounds within the same therapeutic class, with some patents filed prior to 2017.
- Patent families related to the same molecule or class often include filings in the US, Europe, and Latin America.
Key patent documents overlapping BR112017025722
- Similar compositions or methods are protected elsewhere, often in patents filed in the US and Europe.
- Patent databases such as INPADOC show patent families with priority dates spanning the early 2000s to present.
- Brazilian patent operation may face restrictions due to prior art or patent term limitations.
Patent examiner considerations
- The patent claims are subject to novelty, inventive step, and industrial applicability assessments.
- Articulations from prior art citations in patent prosecution shape scope limitations.
- Clinical data or manufacturing methods may provide additional grounds for patent enforcement.
Strategic implications
- The patent's scope and claims suggest potential for exclusivity in Brazil for the covered drug.
- The overlap with existing patents can lead to patent opposition or challenges.
- Enforcement depends on the novelty and non-obviousness of the claims vis-à-vis prior art.
Conclusion
Patent BR112017025722 covers a specific pharmaceutical composition or method relevant for treatment indications, with claims anchored to particular formulations and uses. Its patent landscape in Brazil is characterized by overlap with global patent families and active competition from multinational pharmaceutical companies. The scope's breadth impacts patent enforceability and market exclusivity prospects.
Key Takeaways
- The patent primarily claims a specific drug composition, formulation, or application method.
- Its scope is defined by both broad and narrow claims, depending on the language and specificity.
- The Brazilian patent landscape involves active filings from major pharma companies, with overlaps in global patent families.
- Patent strength depends on overcoming prior art rejections and maintaining validity.
- Competitors and patent challengers can scrutinize the scope for potential infringement or invalidation.
FAQs
1. What is the key advantage of this patent for its holder?
It grants exclusive rights to manufacture, use, or sell the claimed drug in Brazil, potentially blocking competitors.
2. Can existing patents limit the scope of BR112017025722?
Yes. Similar patents from other jurisdictions or prior art disclosures can narrow or invalidate claims.
3. How does Brazil's patent process impact drug patent protection?
Brazil requires novelty, inventive step, and industrial application; the process can include oppositions or rejections based on prior art.
4. What is the typical patent term for pharmaceutical patents in Brazil?
20 years from the filing date, subject to maintenance fees and possible extensions for regulatory delays.
5. How does the patent landscape influence drug development?
It can determine freedom-to-operate, licensing opportunities, and competitive strategy.
References
- INPI. (2023). Patent database access. National Institute of Industrial Property. https://www.inpi.gov.br
- World Intellectual Property Organization (WIPO). (2022). INPADOC patent family data.
- ANVISA. (2023). Drug regulatory procedures and approvals. Brazilian Health Regulatory Agency. https://www.gov.br/anvisa
- European Patent Office (EPO). (2022). Patent landscape reports.
- U.S. Patent and Trademark Office (USPTO). (2022). Patent application databases.
